Jodi Devlin

Insider Reports History

Entity
Individual
Location
C/O Trisalus Life Sciences, Inc., 6272 W. 91 St Avenue, Westminster, CO
Signature
/s/ Sean Murphy, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jodi Devlin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TriSalus Life Sciences, Inc. Chief of Clinical Operations Common Stock 33.4K $189K $5.65 Feb 18, 2025 Direct
TriSalus Life Sciences, Inc. Chief of Clinical Operations Employee Stock Option (right to buy) 63.8K Jan 27, 2025 Direct

Insider Reports Filed by Jodi Devlin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLSI TriSalus Life Sciences, Inc. Feb 18, 2025 1 $0 4 Feb 19, 2025 Chief of Clinical Operations
TLSI TriSalus Life Sciences, Inc. Jan 27, 2025 2 $0 4 Jan 29, 2025 Chief of COMMERC. OPERATIONS
TLSI TriSalus Life Sciences, Inc. Feb 12, 2024 2 $0 4 Feb 14, 2024 PRESIDENT, COMMERC. OPERATIONS
TLSI TriSalus Life Sciences, Inc. Aug 30, 2023 1 $0 4 Aug 31, 2023 President, Therapeutics
TLSI TriSalus Life Sciences, Inc. Aug 28, 2023 0 $0 3 Aug 31, 2023 President, Therapeutics